Amicus Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
16.08.24
/
50%
€10.40
Target price
16.08.25
€14.55
Performance (%)
-7.69%
Price
27.09.24
€9.50
Summary
This prediction is currently active. With a performance of -7.69%, the BUY prediction by JPMorgan_Chase___Co_ is trending in the wrong direction. This prediction currently runs until 16.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amicus Therapeutics Inc. | -2.062% | -2.062% |
iShares Core DAX® | 3.523% | 2.930% |
iShares Nasdaq 100 | 1.026% | 2.688% |
iShares Nikkei 225® | -0.063% | -0.442% |
iShares S&P 500 | 0.557% | 1.759% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at JPMorgan Chase & Co. from $17.00 to $16.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.70
29.09.23
29.09.23
€17.92
29.09.24
29.09.24
-17.95%
02:15
02:15